Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid in digit flexor tendon repair
NCT04178655Phase 1Unknown
- Sponsor
- Rabin Medical Center
- Start
- Nov 2019
- Primary completion
- Nov 2022
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, triple-blind trial of tranexamic acid, sponsored by Rabin Medical Center. Primary endpoint: Anatomic Result at 17 weeks. Status: unknown.
02
Drugs
tranexamic acid
Beyond the preview
Go deeper on NCT04178655.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04178655.